Back

Iodine-123 Metiodobenzylguanidine (MIBG) imaging for selection heart failure patients eligible to an implantable automatic defibrillator (ICD) in primary prevention

27 May 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Chronic Heart Failure – Treatment Implantable Cardioverter-Defibrillator (ICD) HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Chahinez Ketfi

Hospital Bichat-Claude Bernard, Paris (France)

61 More presentations in this session

Presentation thumbnail
Doctor C. Kapelios (Athens, GR)
Abstract Slides
Presentation thumbnail
Presentation thumbnail
Presentation thumbnail
Mrs C. Ariano (Naples, IT)
Abstract
Presentation thumbnail
Professor P. Rossignol (Monaco, MC)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Chronic Heart Failure – Treatment

The Event

Event poster

Heart Failure 2018

27 May 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
3 September 2019
thumbnail
Congress Session
When to implant a primary prevention ICD in patients with structural heart disease: interpreting the 2022 SCD ventricular arrhythmia guidelines
7 April 2024
thumbnail
Congress Presentation
Development of a risk stratification score based on social predictors in patients undergoing implantable cardioverter defibrillator
29 June 2021
thumbnail
Congress Presentation
2 September 2019

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources